Opus Registry: Treatment Patterns With Macitentan In Patients With Pulmonary Arterial Hypertension

被引：0
|
作者：
Chin, K. [1 ]
Channick, R. N. [2 ]
Kim, N. H. [3 ]
Muros-Le Rouzic, E. [4 ]
Selej, M. [5 ]
McLaughlin, V. [6 ]
机构：
[1] Univ Texas Southwestern, Dallas, TX USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Univ Calif San Diego, La Jolla, CA 92093 USA
[4] Actel Pharmaceut Ltd, Allschwil, Switzerland
[5] Actel Pharmaceut US Inc, San Francisco, CA USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2299
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Patient Characteristics and Treatment Patterns with Macitentan in Pulmonary Arterial Hypertension: Insights from the OPUS Registry
    Channick, R.
    Chin, K.
    Kim, N.
    Brand, M.
    Morganti, A.
    Selej, M.
    McLaughlin, V.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (04): : S489 - S490
  • [2] OPUS Registry: Treatment Patterns and Safety of Macitentan in Patients With Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (PAH-SSc)
    Chin, Kelly
    Kim, Nick
    Channick, Richard
    Rouzic, Erwan Muros-Le
    Selej, Mona
    McLaughlin, Vallerie
    CHEST, 2017, 152 (04) : 999A - 1000A
  • [3] CHARACTERIZING PATIENTS TREATED WITH MACITENTAN FOR PULMONARY ARTERIAL HYPERTENSION (PAH) IN THE US OPSUMIT USERS REGISTRY (OPUS)
    McLaughlin, V. V.
    Channick, R. M.
    Lickert, C.
    Pruett, J.
    Selej, M.
    Drake, W.
    VALUE IN HEALTH, 2018, 21 : S55 - S55
  • [4] Patient Characteristics and Treatment Patterns in the Largest Real-World Cohort of Pulmonary Arterial Hypertension Patients Newly Treated with Macitentan: OPsumit® USers (OPUS) Registry
    Channick, R. N.
    Chin, K. M.
    Kim, N. H.
    Melendres-Groves, L.
    Rouzic, E. Muros-Le
    Selej, M.
    McLaughlin, V. V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [5] MACITENTAN FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
    Spikes, L.
    Williamson, T.
    Satterwhite, L.
    DRUGS OF TODAY, 2014, 50 (06) : 401 - 406
  • [6] Macitentan for the treatment of pulmonary arterial hypertension
    Kholdani, Cyrus A.
    Fares, Wassim H.
    Trow, Terence K.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2014, 10 : 665 - 673
  • [7] Macitentan - treatment of pulmonary arterial hypertension
    Campean, I. -A.
    Sadushi-Kolici, R.
    Skoro-Sajer, N.
    Panzenboeck, A.
    Lang, I.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S250 - S251
  • [8] Macitentan for the Treatment of Pulmonary Arterial Hypertension
    Hong, Irene S.
    Coe, Holly V.
    Catanzaro, Linda M.
    ANNALS OF PHARMACOTHERAPY, 2014, 48 (04) : 538 - 547
  • [9] Macitentan for the treatment of pulmonary arterial hypertension
    DuBrock, Hilary M.
    Channick, Richard N.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2014, 8 (04) : 393 - 399
  • [10] Macitentan for the treatment of pulmonary arterial hypertension
    Sood, Namita
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (18) : 2733 - 2739
12345